Literature DB >> 22788256

Comparative effectiveness and child health.

Lisa A Prosser1.   

Abstract

Comparative effectiveness research is expected to play an important role in future clinical and policy decision making in the US; however, the application of comparative effectiveness methodologies to child health requires special attention to aspects of health and healthcare that are specific to children. These special considerations include the role of parent/caregiver as joint decision maker and co-participant in many types of interventions, how the effectiveness of an intervention varies by age and developmental stage, and the difficulties in translating short-term data from childhood into projected effectiveness over the lifespan. Each aspect of comparative effectiveness, such as conducting new studies, synthesizing existing evidence, emphasizing real-world settings, considering multiple decision makers, and measuring patient-relevant outcomes, will require expanded definitions when considered in the context of child health. This paper discusses how comparative effectiveness methods and concepts will differ when applied to child health and suggests a potential role for decision analysis as a method to synthesize data and project long-term outcomes. The initiation of comparative effectiveness studies for children represents an exciting opportunity to provide evidence that can guide clinical and policy decisions for child health.

Entities:  

Mesh:

Year:  2012        PMID: 22788256     DOI: 10.2165/11633830-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  27 in total

1.  Special challenges in comparative effectiveness research on children's and adolescents' health.

Authors:  Lisa A Simpson; Laura Peterson; Carole M Lannon; Sharon B Murphy; Clifford Goodman; Zhaoxia Ren; Anne Zajicek
Journal:  Health Aff (Millwood)       Date:  2010-10       Impact factor: 6.301

2.  Projected costs, risks, and benefits of expanded newborn screening for MCADD.

Authors:  Lisa A Prosser; Chung Yin Kong; Donna Rusinak; Susan L Waisbren
Journal:  Pediatrics       Date:  2010-02       Impact factor: 7.124

3.  Comparative effectiveness research: a progress report.

Authors:  Harold C Sox
Journal:  Ann Intern Med       Date:  2010-08-02       Impact factor: 25.391

4.  Estimating the energy gap among US children: a counterfactual approach.

Authors:  Y Claire Wang; Steven L Gortmaker; Arthur M Sobol; Karen M Kuntz
Journal:  Pediatrics       Date:  2006-12       Impact factor: 7.124

5.  Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials.

Authors:  C Daniel Mullins; Danielle Whicher; Emily S Reese; Sean Tunis
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

6.  Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.

Authors:  L A Prosser; A A Stinnett; P A Goldman; L W Williams; M G Hunink; L Goldman; M C Weinstein
Journal:  Ann Intern Med       Date:  2000-05-16       Impact factor: 25.391

Review 7.  Cost effectiveness of preventive interventions in type 2 diabetes mellitus: a systematic literature review.

Authors:  Sylvia M C Vijgen; Mirjam Hoogendoorn; Caroline A Baan; G Ardine de Wit; Wien Limburg; Talitha L Feenstra
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

8.  Using radiation risk models in cancer screening simulations: important assumptions and effects on outcome projections.

Authors:  Chung Y Kong; Janie M Lee; Pamela M McMahon; Kathryn P Lowry; Zehra B Omer; Jonathan D Eisenberg; Pari V Pandharipande; G Scott Gazelle
Journal:  Radiology       Date:  2012-03       Impact factor: 11.105

9.  The National Children's Study: a 21-year prospective study of 100,000 American children.

Authors:  Philip J Landrigan; Leonardo Trasande; Lorna E Thorpe; Charon Gwynn; Paul J Lioy; Mary E D'Alton; Heather S Lipkind; James Swanson; Pathik D Wadhwa; Edward B Clark; Virginia A Rauh; Frederica P Perera; Ezra Susser
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

Review 10.  Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.

Authors:  Lisa A Prosser; James K Hammitt; Ron Keren
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.